Akros SCHK HK-Global Heavy Asset Low Obsolescence Index

Canadian Natural Resources is scheduled to release its Q2 2026 financial results on August 6, 2026, expected.

Linde is scheduled to release its second quarter 2026 financial results on July 31, 2026, before the market opens, with an investor conference call to follow. Analysts forecast an EPS of approximately $4.49, while company guidance is $4.40-$4.50. High importance is estimated due to typical price volatility around earnings, scheduled.

Q2 2026 earnings results scheduled to be released on July 31, 2026. A medium impact is estimated as earnings reports typically trigger significant price volatility, scheduled

United Parcel Service is scheduled to release its Q2 2026 earnings results on 2026-07-28, with a conference call at 8:30 AM ET; analysts forecast an EPS of approximately $1.66; medium importance estimated due to expected earnings impact, scheduled.

Q2 2026 earnings results scheduled to be released after market close on July 28, 2026, with a conference call the following morning; analysts forecast EPS around $1.99-$2.00 forecasted. Market reaction not yet occurred; earnings releases typically drive significant volatility, estimated at ~5% impact expected.

HCA Healthcare is scheduled to report Q2 2026 earnings on July 24, 2026; high importance is estimated due to the potential for significant price movement typical of quarterly results, scheduled.

Canadian National Railway is scheduled to report its Q2 2026 financial and operating results on July 24, 2026, scheduled. A medium impact is estimated as earnings reports typically drive significant price movement.

Union Pacific is scheduled to release its second quarter 2026 financial and operating results on July 23, 2026, before the market opens, which is an event with potential for significant price impact, scheduled.

CSX Corp. to release Q2 2026 financial and operating results after market close on July 22, 2026, with a conference call to follow, scheduled.

PepsiCo reported Q2 2026 results with revenue of $24.18 billion, beating analyst expectations. However, earnings per share of $2.20 slightly missed some consensus estimates, leading to a minor pre-market stock decline. The company reaffirmed its full-year 2026 guidance.

Barclays downgraded HCA stock to Equal Weight from Overweight and cut its price target on July 8, 2026, citing concerns over Medicaid policy risk and volume uncertainty.

The company signaled in a regulatory filing on July 7, 2026, that changes in oil prices would boost its second-quarter upstream earnings by $3.5 billion to $3.9 billion compared to the first quarter, with total profit potentially rising by about $5 billion.